These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 208281)

  • 1. Factors which influence inactivation of vesicular stomatitis virus by fresh human serum.
    Thiry L; Cogniaux-Le Clerc J; Content J; Tack L
    Virology; 1978 Jun; 87(2):384-93. PubMed ID: 208281
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of infectious virions which are vesicular stomatitis virus pseudotypes of murine type C virus.
    Livingston DM; Howard T; Spence C
    Virology; 1976 Apr; 70(2):432-9. PubMed ID: 57669
    [No Abstract]   [Full Text] [Related]  

  • 3. Vesicular stomatitis viruses resistant to the methylase inhibitor sinefungin upregulate RNA synthesis and reveal mutations that affect mRNA cap methylation.
    Li J; Chorba JS; Whelan SP
    J Virol; 2007 Apr; 81(8):4104-15. PubMed ID: 17301155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The switch from transcription to replication of a negative-strand RNA virus.
    Wertz GM; Howard MB; Davis N; Patton J
    Cold Spring Harb Symp Quant Biol; 1987; 52():367-71. PubMed ID: 2841068
    [No Abstract]   [Full Text] [Related]  

  • 5. Brefeldin A blocks protein glycosylation and RNA replication of vesicular stomatitis virus.
    Irurzun A; Pérez L; Carrasco L
    FEBS Lett; 1993 Dec; 336(3):496-500. PubMed ID: 8282118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A possible effect of viral proteins on the specificity of interference by defective vesicular stomatitis virus particles.
    Schnitzlein WM; Reichmann ME
    Virology; 1977 Jul; 80(2):275-88. PubMed ID: 70105
    [No Abstract]   [Full Text] [Related]  

  • 7. Pseudotypes of vesicular stomatitis virus with coat antigen of bovine leukaemia virus--VSV (BLV): antigenic surface mosaic and the roles of precipitating antibodies and polycations.
    Závadová Z; Závada J
    Acta Virol; 1980 May; 24(3):166-74. PubMed ID: 6158852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assembly of membrane glycoproteins studied by phenotypic mixing between mutants of vesicular stomatitis virus and retroviruses.
    Weiss RA; Bennett PL
    Virology; 1980 Jan; 100(2):252-74. PubMed ID: 6243428
    [No Abstract]   [Full Text] [Related]  

  • 9. Recombinant vesicular stomatitis (Indiana) virus expressing New Jersey and Indiana glycoproteins induces neutralizing antibodies to each serotype in swine, a natural host.
    Martinez I; Barrera JC; Rodriguez LL; Wertz GW
    Vaccine; 2004 Sep; 22(29-30):4035-43. PubMed ID: 15364454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudotypes of vesicular stomatitis virus determined by exogenous and endogenous avian RNA tumor viruses.
    Love DN; Weiss RA
    Virology; 1974 Jan; 57(1):271-8. PubMed ID: 4362025
    [No Abstract]   [Full Text] [Related]  

  • 11. Nucleotide sequence analysis of the L gene of vesicular stomatitis virus (New Jersey serotype): identification of conserved domains in L proteins of nonsegmented negative-strand RNA viruses.
    Barik S; Rud EW; Luk D; Banerjee AK; Kang CY
    Virology; 1990 Mar; 175(1):332-7. PubMed ID: 2155516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface structure of vesicular stomatitis virus.
    Cartwright B; Smale CJ; Brown F
    J Gen Virol; 1969 Jul; 5(1):1-10. PubMed ID: 4309923
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of interferon on vesicular stomatitis virus proteins.
    Friedman RM; Maheshwari RK
    Nature; 1983 Apr; 302(5910):728. PubMed ID: 6300697
    [No Abstract]   [Full Text] [Related]  

  • 14. Replication of vesicular stomatitis virus: the effect of purified interfering component.
    Wild TF
    J Gen Virol; 1972 Dec; 17(3):295-305. PubMed ID: 4346652
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of primary transcription of vesicular stomatitis virus by prostaglandin A1.
    Bader T; Ankel H
    J Gen Virol; 1990 Dec; 71 ( Pt 12)():2823-32. PubMed ID: 2177081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shope fibroma virus-induced facilitation of vesicular stomatitis virus adsorption and replication in nonpermissive cells.
    Chen CY; Crouch NA
    Virology; 1978 Mar; 85(1):43-62. PubMed ID: 206013
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of interferon treatment on vesicular stomatitis virus (VSV): release of unusual particles with low infectivity.
    Maheshwari RK; Friedman RM
    Virology; 1980 Mar; 101(2):399-407. PubMed ID: 6244697
    [No Abstract]   [Full Text] [Related]  

  • 18. Exponential increases of RNA virus fitness during large population transmissions.
    Novella IS; Duarte EA; Elena SF; Moya A; Domingo E; Holland JJ
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5841-4. PubMed ID: 7597039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SV40 tumor rejection induced by vesicular stomatitis virus bearing SV40 tumor-specific transplantation antigen (SV40-TSTA). I. Specificity of immunoprotection and effect of enzyme treatment on TSTA activity.
    Ansel S; Huet C; Tournier P
    Int J Cancer; 1977 Jul; 20(1):51-60. PubMed ID: 71274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vesicular stomatitis virus pseudotype with neutralization antigen of tick-borne encephalitis virus.
    Dragúnová J; Greśíková M
    Acta Virol; 1986 Jul; 30(4):346-8. PubMed ID: 2876617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.